Paul Glavine - 30 Sep 2026 Form 4 Insider Report for Helus Pharma Inc. (HELP)

Reporting relationship: Chief Growth Officer, Director
Issuer ticker: HELP
Reported as of: 30 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Oct 2026, 20:12:39 UTC
Prior SEC filing: 11 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Paul Glavine

Key filing fact

Paul Glavine filed Form 4 for Helus Pharma Inc. (HELP) on 01 Oct 2026.

Key facts

This page summarizes Paul Glavine's Form 4 filing for Helus Pharma Inc. (HELP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Oct 2026, 20:12.

Change

Previous filing in this sequence was filed on 11 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002118509 Primary reporting owner

Glavine Paul

Relationship: Chief Growth Officer, Director
Address: C/O HELUS PHARMA INC., 100 KING STREET W., SUITE 5600, TORONTO, ONTARIO, CANADA
Signature: /s/ Paul Glavine
Signature date: 01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HELP transaction

Common Shares

Award

Transaction value
Shares: +248,000
Change %: +5.5%
Price
Shares after: 4,750,191
Date: 30 Sep 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents grant of 248,000 restricted stock units ("RSUs") on September 30, 2026, with immediate vesting.

Footnote F2

Each ("RSU") represents a right to receive one share of the Issuer's common stock.

Footnote F3

Includes 230,941 shares previously reported as indirect holdings by the PLG Family Trust, which have been transferred to the Reporting Person. Due to rounding, the number of shares has been reduced to 230,939.